Skip to main content

Analyzing the Growth and Expansion of the Neurostimulation Devices Market

The global healthcare economic burden, at present, is primarily characterized by major contributors such as chronic pain and neurological disorders. The annual societal cost for chronic pain and neurological disorders accounted for $635 billion and $789 billion respectively in the U.S., in 2014. Opioids are one of the most preferred medicines for the treatment of chronic pain, however, the side-effects associated with opioids have resulted in a decline in their overall usage and sale.
Consequently, the increasing cases of neurological disorders and the need for a novel approach for the treatment of such diseases has led to the advent of neuromodulation technologies. The rapid shift of the healthcare industry toward neurostimulation devices from opioids and other conventional treatment techniques can be attributed to the efficient, safe, and targeted approach of neurostimulation devices.



BIS Research recently published a market intelligence report titled “Global Neurostimulation Devices Market- Analysis and Forecast (2019-2024),” projecting the expected growth of the neurostimulation devices market across the globe during the forecast period, 2019-2024. As per the published report, the market is anticipated to witness a compound annual growth rate of 9.23% during the forecast period and is expected to reach $11.97 billion by 2024.  
Neurostimulation devices can be either implantable or non-implantable. The various implantable neurostimulation devices include spinal cord stimulation, auditory brainstem implant, vagus nerve stimulation, sacral nerve stimulation, hypoglossal nerve stimulation, and deep brain stimulation devices. Based on the analysis of the market by BIS Research, the spinal cord stimulation segment dominated the neurostimulation devices market by acquiring the largest market share in 2017. Moreover, the auditory brainstem implant segment is anticipated to lead the market in terms of growth rate during the forecast period.
Further, under the application segment, the global neurostimulation devices market includes pain management, hearing loss, epilepsy, depression, Parkinson’s disease, and urinary and fecal incontinence. Amongst these, hearing loss application segment is expected to grow at the fastest CAGR, during the forecast period.
Product launches, and mergers and acquisitions are the most adopted strategies by players in the global neurostimulation devices market. Other strategies include joint ventures, partnerships, and collaborations. Some of the leading players functioning in the market are Cochlear Ltd., Abbott Laboratories, Neuronetics Inc., Mainstay Medical International plc, Nexeon MedSystems Inc., and Helius Medical Technology.

Comments

Post a Comment

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...
2 comments
Read more

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...
1 comment
Read more

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...
1 comment
Read more